NEOCHROMOSOME, INC.
Biotech · Acquired
Gene-edited pluripotent stem cells with programmable HLA Class 1 haplotypes for immune-matched allogeneic cell therapy
- Grants
- $1.1M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Yeast synthetic biology platform for pathway-level antimicrobial screens | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Plug-and-Play HLA for Safer and Personalized Off-the-Shelf Cell Therapies using big-DNA technology | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Plug-and-Play HLA for Safer and Personalized Off-the-Shelf Cell Therapies using big-DNA technology | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Synthetic Neo-Amplicon Production System for High Capacity Therapeutic Gene Delivery | $323,408 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3056 | NANONEWRON LLC | — | — |
| 3057 | CatalYm | — | — |
| 3058 | TFC BIOSCIENCES, INC. | — | — |
| 3059 | NEOCHROMOSOME, INC. | — | — |
| 3060 | RNA NANOTHERAPEUTICS LLC | — | — |
| 3061 | Parabolica Therapeutics, Inc. | — | $50K |
| 3062 | Centessa Pharmaceuticals | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Systems For Nucleic Acid Synthesisapplication
- Methods And Systems For Nucleic Acid Synthesisapplication
- Methods And Systems For Nucleic Acid Synthesisapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.